Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Frank Perabo, MD, PhD
ESSA Pharmaceuticals Corp.
Study Director - Kim N. Chi, MD
British Columbia Cancer Agency - Vancouver Centre
Principal Investigator - Robert B. Montgomery, MD
Seattle Cancer Care Alliance
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- British Columbia Cancer Agency - Vancouver Centre
Vancouver, British Columbia, Canada
- Scottsdale Healthcare Hospitals Dba Honorhealth
Scottsdale, Arizona, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2015
- Primary completion
- 31 Dec 2017
- Completion
- 31 Dec 2017
- Last update posted
- 1 Mar 2018
- Registered enrollment
- 28
- Registry id
- NCT02606123
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.